Vulnusan® (Ointment) Instructions for Use
Marketing Authorization Holder
Sopharma, JSC (Bulgaria)
ATC Code
D11AX (Other drugs used in dermatology)
Dosage Form
| Vulnusan® | Ointment for topical and external use 12 g/100 g: 45 g tube |
Dosage Form, Packaging, and Composition
Ointment for topical and external use is homogeneous, ranging from light yellow to yellow in color, with a characteristic odor.
| 100 g | |
| Pomorie Lake mother liquor (stabilized lye) | 12 g |
Excipients: Ricinus communis seed oil (castor oil) – 20 g, carmellose sodium – 3 g, lanolin – 32 g, sodium benzoate – 0.5 g, purified water – 32.5 g.
45 g – aluminum tubes (1) – cardboard packs.
Clinical-Pharmacological Group
A drug with anti-inflammatory, antimicrobial, and tissue regeneration-improving action
Pharmacotherapeutic Group
Topical anti-inflammatory agent of natural origin
Pharmacological Action
A topical agent of natural origin, obtained by processing the mother liquor of Pomorie Lake. It exerts anti-inflammatory, antimicrobial, and tissue regeneration-improving action.
The Pomorie Lake mother liquor contains macro- and microelements (magnesium, potassium, calcium, sodium, chlorine, bromine, iron, manganese, copper, cobalt, iodine, molybdenum, zinc, bismuth, selenium), as well as colloids, acids, alkalis, and other substances of organic origin.
Indications
Purulent wounds of various origins: infected, surgical, superficial purulent processes (including pararectal and post-injection abscesses), trophic ulcers, post-traumatic and atherosclerotic wounds; drug-induced skin maceration; ulcerations in Buerger’s disease, varicose ulcers, cervical erosion, fissures of the mammary gland nipple.
ICD codes
| ICD-10 code | Indication |
| I73.1 | Obliterative thromboangiitis [Buerger's disease] |
| I83.2 | Varicose veins of lower extremities with ulcer and inflammation |
| K60 | Fissure and fistula of anus and rectum |
| K61 | Abscess of anal and rectal regions |
| L02 | Cutaneous abscess, furuncle and carbuncle |
| N64.0 | Fissure and fistula of nipple |
| N86 | Erosion and ectropion of cervix |
| T79.3 | Posttraumatic wound infection, not elsewhere classified |
| ICD-11 code | Indication |
| 1B75.0 | Furuncle |
| 1B75.1 | Carbuncle |
| 1B75.2 | Furunculosis |
| 1B75.3 | Pyogenic skin abscess |
| 4A44.8 | Thromboangiitis obliterans |
| BD74.Z | Chronic venous insufficiency of lower extremities, unspecified |
| DB50.Z | Fissure or fistula of anal region, unspecified |
| DB70.0Z | Abscess of anal and rectal region, unspecified |
| DE2Z | Diseases of the digestive system, unspecified |
| GA15.1 | Erosion or ectropion of cervix |
| GB23.1 | Fissure or fistula of nipple |
| NF0A.3 | Posttraumatic wound infection, not elsewhere classified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply externally to the affected area after thorough cleansing and drying.
For purulent wounds, trophic ulcers, and post-traumatic wounds, apply a thin layer of ointment 1 to 2 times daily.
For superficial purulent processes such as abscesses and furuncles, apply directly to the lesion once or twice daily.
In cases of cervical erosion or nipple fissures, apply the ointment carefully to the affected site once daily.
Use a sterile gauze dressing to cover the treated area after application.
Change the dressing and reapply the ointment according to the severity of the condition and the amount of exudate.
The duration of treatment is determined by the rate of tissue regeneration and clinical response.
Discontinue use and consult a physician if allergic reactions such as skin rash or urticaria occur.
Avoid contact with eyes and mucous membranes. Wash hands thoroughly before and after application.
Adverse Reactions
Allergic reactions skin rash, urticaria, angioedema.
Local reactions pain upon application to ulcers.
Contraindications
Pregnancy; children under 12 years of age; hypersensitivity to the active substance.
Use in Pregnancy and Lactation
Use is contraindicated during pregnancy.
Use of this product during lactation is possible according to indications. Use does not interfere with feeding the child and does not require discontinuation of breastfeeding.
Pediatric Use
Contraindication: children under 12 years of age.
Special Precautions
If necessary, it can be used with occlusive dressings.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer